Daniel M. Bendheim - 04 Aug 2026 Form 4 Insider Report for PHIBRO ANIMAL HEALTH CORP (PAHC)

Reporting relationship: President and CEO, Director
Issuer ticker: PAHC
Reported as of: 04 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Aug 2026, 20:10:19 UTC
Prior SEC filing: 02 Jul 2026
Next SEC filing: 10 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Judith Weinstein, as Attorney-in-Fact for Daniel Bendheim

Key filing fact

Daniel M. Bendheim filed Form 4 for PHIBRO ANIMAL HEALTH CORP (PAHC) on 06 Aug 2026.

Key facts

This page summarizes Daniel M. Bendheim's Form 4 filing for PHIBRO ANIMAL HEALTH CORP (PAHC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 06 Aug 2026, 20:10.

Change

Previous filing in this sequence was filed on 02 Jul 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001601576 Primary reporting owner

Bendheim Daniel M

Relationship: President and CEO, Director
Address: 300 FRANK W. BURR BLVD., STE 21, TEANECK
Signature: /s/ Judith Weinstein, as Attorney-in-Fact for Daniel Bendheim
Signature date: 06 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PAHC transaction

Class A Common Stock

Other

Transaction value
Shares: -486
Change %: -12%
Price: $36.60^*
Shares after: 3,478
Date: 04 Aug 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares sold in a broker assisted cashless exercise program to satisfy tax withholding obligations upon the receipt of Class A Common Stock in connection with the vesting and settlement of restricted stock units.